• Sort Blog:
  • All
  • Problemi metodologici
  • Necrologio
  • Flogosi acute o croniche
  • Malattie da infezione
  • Politica sanitaria
  • Malattie del viaggiatore
  • Patogenesi
  • Malnutrizione
  • Tossinfezion alimentari
  • Squilibri ormonali
  • Uncategorized
  • Malattie da prioni4
  • Rickettsie
  • Fattori di rischio
  • Malattie neurologiche
  • Malattie autoimmuni
  • Batteriologia
  • Malattie da prioni
  • Terapie antinfettive
  • Farmaci antinfiammatori
  • Malattie delle articolazioni
  • Malattie ortopediche
  • Micologia
  • Immunologia
  • Tossicodipendenza
  • Sepsi neonatale
  • inflammatory bowel disease (IBD)
  • Infezioni urinarie
  • Infezioni associate all'assistenza sanitaria
  • Veterinaria
  • Prevenzione
  • Sepsi
  • Febbre
  • Malattie dell'occhio
  • Parassitologia
  • Infezioni atipiche
  • Marcatori d'infezione
  • Varie
  • Terapie palliative
  • Virologia
  • Zoonosi
  • Problemi diagnostici
  • Microbioma
  • Farmacologia
  • Antibiotici
  • Test diagnostici
  • Trapianti d'organo o tessuti
  • Neoplasie
  • Eziologia
  • Micobatteriologia
  • Tossinfezioni alimentari
  • Tecnologia
  • Metagenomica
  • Malattie respiratorie
  • Avvisi ai lettori
  • Fagi
  • Intossicazione alimentare
  • Malattie Tropicali
  • Malattie infiammatorie
  • Ultime notizie
  • antimicotici
  • Genomica
  • Malattie Metaboliche
  • Nutrizione
  • Mal. a trasm. sessuale
  • Medicina ambientale
  • Semeiotica
  • Probiotici
  • Tossicologia
  • Linee guida - Raccomandazioni
  • Epidemie infettive
  • Eruzioni mucocutanee da infezione
  • Marcatore
  • Malattie cardiocircolatorie
  • Vaccinazioni
  • Prognosi delle infezioni
  • Malattie dermatologiche
  • Oculistica
  • Malformazioni congenite
  • Argomento generico
  • Disinfezione
  • Oncologia
  • Malattie genetiche
  • Malattie renali

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.Lagi F, Trevisan S, Piccica M, Graziani L, Basile G, Mencarini J, Borchi B, Menicacci L, Vaudo M, Scotti V, Fabbri A, Bandini G, Tozzetti C, Berni A, Aiezza N, Pestelli G, Turchi V, Pignone AM, Poggesi L, Nozzoli C, Morettini A, Rossolini GM, Bartoloni A.Int J Infect Dis. 2021 Jul;108:231-236. doi: 10.1016/j.ijid.2021.04.065. Epub 2021 Apr 24.PMID: 33901656 Free PMC article.

Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia

Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia.Camici M, Zuppi P, Lorenzini P, Scarnecchia L, Pinnetti C, Cicalini S, Nicastri E, Petrosillo N, Palmieri F, D’Offizi G, Marchioni L, Gagliardini R, Baldelli R, Schininà V, Pianura E, Di Stefano F, Curcio S, Ciavarella L, Ippolito G, Girardi E, Vaia F, Antinori A; ReCoVeRi Study Group.Int J Infect Dis. 2021 Jul;108:244-251. doi: 10.1016/j.ijid.2021.05.042. Epub 2021 May 20.PMID: 34023492 Free PMC article.

Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19

Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.Hirotsu Y, Sugiura H, Maejima M, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.Int J Infect Dis. 2021 Jul;108:263-269. doi: 10.1016/j.ijid.2021.05.067. Epub 2021 Jun 1.PMID: 34082089 Free PMC article.

Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study

.Pagnesi M, Inciardi RM, Lombardi CM, Agostoni P, Ameri P, Barbieri L, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Dalla Vecchia LA, Danzi GB, Di Pasquale M, Gaudenzi M, Giovinazzo S, Gnecchi M, Guazzi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Sarullo F, Sinagra G, Tedino C, Tomasoni D, Volterrani M, Zaccone G, Senni M, Metra M.Int J Infect Dis. 2021 Jul;108:270-273. doi: 10.1016/j.ijid.2021.05.056. Epub 2021 May 28.PMID: 34052406 Free PMC article.

Impact of the COVID-19 pandemic on tuberculosis management in Spain


Impact of the COVID-19 pandemic on tuberculosis management in Spain.
Aznar ML, Espinosa-Pereiro J, Saborit N, Jové N, Sánchez Martinez F, Pérez-Recio S, Vitoria A, Sanjoaquin I, Gallardo E, Llenas-García J, Pomar V, García IO, Cacho J, Goncalves De Freitas L, San Martin JV, García Rodriguez JF, Jiménez-Fuentes MÁ, De Souza-Galvao ML, Tórtola T, Zules R, Molina I, Sánchez-Montalvá A.Int J Infect Dis. 2021 Jul;108:300-305. doi: 10.1016/j.ijid.2021.04.075. Epub 2021 Apr 27.PMID: 33930543 Free PMC article.

Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial

Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial.Siami Z, Aghajanian S, Mansouri S, Mokhames Z, Pakzad R, Kabir K, Norouzi M, Soleimani A, Hedayat Yaghoobi M, Shadabi S, Tajbakhsh R, Kargar Kheirabad A, Mozhgani SH.Int J Infect Dis. 2021 Jul;108:306-308. doi: 10.1016/j.ijid.2021.04.043. Epub 2021 Apr 18.PMID: 33878462 Free PMC article.

Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia – A Descriptive Whole-body Autopsy Series

Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia – A Descriptive Whole-body Autopsy Series.Himwaze CM, Telendiy V, Maate F, Mupeta S, Chitalu C, Chanda D, Julius P, Mumba C, Marimo C, Hamukale A, Mulenga L, Shibemba AL, Zumla A, Mucheleng’anga LA.Int J Infect Dis. 2021 Jul;108:363-369. doi: 10.1016/j.ijid.2021.06.013. Epub 2021 Jun 17.PMID: 34146690 Free PMC article.

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study.Kamstrup P, Sivapalan P, Eklöf J, Hoyer N, Ulrik CS, Pedersen L, Lapperre TS, Harboe ZB, Bodtger U, Bojesen RD, Håkansson KEJ, Tidemandsen C, Armbruster K, Browatzki A, Meteran H, Meyer CN, Skaarup KG, Lassen MCH, Lundgren JD, Biering-Sørensen T, Jensen JU.Int J Infect Dis. 2021 Jul;108:370-376. doi: 10.1016/j.ijid.2021.05.076. Epub 2021 Jun 1.PMID: 34087484 Free PMC article.

Evaluation of sample treatments in a safe and straightforward procedure for the detection of SARS-CoV-2 in saliva

Evaluation of sample treatments in a safe and straightforward procedure for the detection of SARS-CoV-2 in saliva.Rubio CP, Franco-Martínez L, Resalt CS, Torres-Cantero A, Martinez-Morata I, Bernal E, Alcaraz MJ, Vicente-Romero MR, Martínez-Subiela S, Tvarijonaviciute A, Cerón JJ.Int J Infect Dis. 2021 Jul;108:413-418. doi: 10.1016/j.ijid.2021.05.053. Epub 2021 May 24.PMID: 34044144 Free PMC article.

La Segreteria AMCLI effettua la chiusura il giorno 26 aprile 2024 in occasione del ponte del 25 aprile.